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Abstract
Ubiquitin is a highly versatile post-translational modification that controls virtually all types of
cellular events. Over the past ten years we have learned that diverse forms of ubiquitin
modifications and of ubiquitin binding modules co-exist in the cell, giving rise to complex networks
of protein:protein interactions. A central problem that continues to puzzle ubiquitinologists is how
cells translate this myriad of stimuli into highly specific responses. This is a classical signalling
problem. Here, we draw parallels with the phosphorylation signalling pathway and we discuss the
expanding repertoire of ubiquitin signals, signal tranducers and signalling-regulated E3 enzymes. We
examine recent advances in the field, including a new mechanism of regulation of E3 ligases that
relies on ubiquitination.
Background
Cells use a system of post-translational protein modifica-
tions to generate and transmit signals in almost every
pathway. One of them is ubiquitination. When appended
to target proteins ubiquitin (Ub) can affect their localiza-
tion, activity, structure and interaction partners. Similarly
to the phospho-based signal, the ubiquitin signal is recog-
nized by specific domains (Ubiquitin Binding Domains,
UBDs), carried by proteins (Ub receptors) that represent
signal transducers. More parallels can be drawn with
phosphorylation: ubiquitination is reversible thanks to
deubiquitinating enzymes (DUBs) and it is inducible by
various stimuli. Compared to phosphorylation, the signal
generated by the 76-residue Ub protein is certainly more
complex. Ub can be appended as a monomer or as isopep-
tide-linked polymers named polyubiquitin chains. The
existence of a vast array of Ub signals raises the question
of how the specificity of signal recognition might be
achieved. Indeed, the molecular requirements for recogni-
tion of the various known Ub signals are poorly under-
stood and form a central question in the field.
Here, we will discuss recent studies that shed new light on
the Ub code and that regard the topology of Ub signals,
the identification of new UBDs and the regulation of the
critical enzymes of the signalling cascade, namely, the E3
ligases.
Ubiquitin chain complexity: generation of 
signalling diversity
Substrate proteins can be modified by Ub in different
ways (Figure 1). Monoubiquitination is the attachment of
one Ub moiety to a single lysine residue. This modifica-
tion is a reversible, non-proteolytic signal involved in
endocytosis, endosomal sorting, histone regulation, DNA
repair, virus budding and nuclear export (reviewed in [1-
4]). A variation of this theme occurs when several lysine
residues of a substrate are modified by a single Ub mole-
cule, giving rise to multiple monoubiquitination that
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Ubiquitin itself contains seven lysine residues that can be
potentially used as acceptors for the attachment of other
Ub molecules, allowing the formation of different types of
Ub chains (polyubiquitination, Figure 1). Indeed, it has
recently been shown that all seven lysine residues are used
in vivo for chain formation [8,9]. However, it is currently
not known if all of the linkages have a specific function.
Lysine linkage is a central issue, since different polyUb
chains contribute to the generation of diversity in Ub-
dependent signalling. The first genetic evidence that struc-
turally different chains might represent functionally dis-
tinct signals, came from a study showing that yeast cells
expressing Ub-K63R are defective in DNA repair, but still
proteolytically competent [10]. The simplest idea to
explain chain recognition is based on possible different
topologies adopted by different chain types. Such a con-
cept would help to rationalize how cells interpret the
diversity of Ub signals and translate them into specific
biological responses.
The best-studied examples are chains of four or more Ub
moieties linked through lys48. This form of chain targets
proteins for degradation via the 26S proteasome [11,12].
Interestingly, NMR and crystallographic studies have
shown that lys48-linked chains adopt a closed conforma-
tion, whereby hydrophobic residues of two adjacent Ub
molecules are exposed at the interface and contact each
other [13-16]. Such structural attributes appear to be
required for the recognition by the proteasomal subunits
[12,17].
Ub-chains formed through lys63 have also been subjected
to intense scrutiny. Similarly to monoubiquitin, such
chains generate a non-proteolytic signal involved in DNA
repair, transcriptional regulation, endocytosis and activa-
tion of protein kinases [18-20]. NMR data have confirmed
the existence of a conformational difference between
lys48- and lys63-linked chains, with the latter adopting an
extended, linear conformation of Ub units arranged head
to tail [21,22]. This type of structure suggests that lys63
chains might be recognized as a signal topologically simi-
lar to monoubiquitin. Indeed, while monoUb is sufficient
to stimulate rapid internalization for the majority of yeast
The ubiquitin pathwayFigure 1
The ubiquitin pathway. A) Schematic representation of the ubiquitination process. A hierarchical set of three types of 
enzyme is required for substrate ubiquitination: ubiquitin-activating (E1), ubiquitin-conjugating (E2) and ubiquitin-protein ligase 
(E3) enzymes. The two major classes of E3 ligases are depicted. B) Schematic representation of the different Ub modifications 
with their functional roles. The question mark indicates that the functions of branched chains are largely unknown.Page 2 of 12
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maximal internalization rates of a subset of nutrient per-
meases [18,25]. A similar behaviour has been observed in
mammalian cells. MHC class I molecules [26] and nerve
growth factor receptor TrkA [27] require lys63 chains for
internalization, while EGFR is modified by both monoUb
and lys63 chains [5,7].
Much less is known about the precise function and topol-
ogy of chains that are linked through lys6, lys11, lys27,
lys29 and lys33 [3,12,20] and structural analysis are
needed to understand if these chains also have peculiar
conformational properties.
New pioneering studies demonstrating that atypical,
mixed polyUb chains can be formed, point to an addi-
tional level of complexity in the Ub system. Several groups
have reported the identification of branched chains con-
taining different types of linkages, but their functions still
remain unclear [8,28-30]. These findings are based exclu-
sively on in vitro reconstituted systems, often performed
using lysine-to-arginine mutant forms of Ub. Despite the
proved utility of these molecular approaches they remain
indirect and susceptible of criticisms. Unfortunately, this
is our resolution limit at present. More work is required to
understand the relevance of these different lysine linkages
in vivo and, in this respect, the development of novel diag-
nostic tools, such as linkage-specific antibodies or innova-
tive mass spectrometry strategies, would be of great help.
Ub and endocytosis: EGFR as a case study
Receptor Tyrosine Kinases (RTKs) control different bio-
logical processes including cell proliferation, differentia-
tion and survival [31]. The prototype of RTKs is the
Epidermal Growth Factor Receptor (EGFR), which plays
critical roles in physiological and pathological processes
in epithelial cells [31]. Once activated by its cognate lig-
and, the EGFR undergoes dimerization and trans-phos-
phorylation at different tyrosines, which serve as docking
sites for several signalling/adaptor molecules [32]. One of
these is the E3 ligase Cbl, which mediates ubiquitination
of the receptor [33,34]. In a first set of studies, EGFR was
shown to be primarily modified by multiple monoubiq-
uitination in vivo [5,6] and a single Ub moiety was dem-
onstrated to be sufficient to drive receptor internalization
[5]. More recently, a challenging study based on a mass
spectrometry approach has shown that, in addition to
multiple monoubiquitination, the EGFR is modified by
short lys63-linked chains within the kinase domain [7].
Although we cannot exclude that these two EGFR modifi-
cations may play distinct role in endocytosis, the struc-
tural data discussed previously argue for a topologically-
related signal. The mechanism through which lys63-
linked chains could further stimulate internalization is
not known at the moment. The simplest explanation is
that Ub lys63 chains might work as a tandem monoUb
signal, increasing the affinity for Ub receptors that operate
at the various stations along the endocytic pathway, but
other explanations are also possible (for detailed exam-
ples see [4]).
The best characterized role for receptor ubiquitination is
to negatively regulate signalling by targeting receptors for
lysosomal degradation (reviewed in [35-37]). The require-
ment for Ub at the initial step of internalization of EGFR
was rather controversial [38-41]. The studies we con-
ducted under physiological conditions helped to resolve
this issue and unveiled the importance of ligand concen-
tration in the internalization process [42]. We found that
the receptor uses different pathways depending on its
ubiquitination state, which is a direct consequence of the
amount of EGF used to stimulate it. Indeed, at low doses
of EGF (1.5 ng/ml), only clathrin-dependent endocytosis
is active. For this pathway, receptor ubiquitination is not
necessary. Accordingly, mutations, either targeting the
tyrosine docking-site for Cbl or the ubiquitinated lysines,
resulting in a Ub-defective receptor, abrogate receptor
down-regulation but not its internalization via the clath-
rin pathway [7,39,40,42]. At higher, but still physiologi-
cally relevant, EGF concentration (20 ng/ml), an
additional clathrin-independent, raft-dependent pathway
comes into play, concomitantly with ubiquitination of
the receptor. Experiments with EGFR mutants that can no
longer be ubiquitinated or engineered to have Ub as the
only intracellular signal (EGFR-Ub chimera) confirm that
Ub is the major device that directs the receptor to the raft
pathway [42]. A schematic view of the different entry
routes of EGFR in HeLa cells and their regulation as a
function of EGF dose is depicted in Figure 2.
The existence of distinct, highly regulated internalization
pathways, raises the possibility that they might be
involved in the generation of signalling diversity, by tar-
geting the receptor to different fates, as was shown in the
case of the TGFβ receptor [43]. To date, the impact of the
two pathways on the final biological outcomes of EGFR
signalling is not known and remains a challenging ques-
tion. We recently found that while the raft-dependent
pathway is preferentially associated with EGFR degrada-
tion, clathrin-dependent internalization appears to con-
tribute primarily to EGFR recycling and signalling (SS and
SP, unpublished).
Three adaptors, eps15, eps15R and epsin, are recruited to
the EGFR at the plasma membrane upon ligand activa-
tion. These proteins have been traditionally linked to
clathrin-dependent endocytosis, due to their multiple
interactions with the clathrin apparatus [44-49]. Recent
evidence, while confirming their involvement in the clath-
rin pathway with an optimizing function, point to a pre-Page 3 of 12
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Dose-dependent entry routes for the EGFR. A) At low doses of EGF, EGFR is mainly internalized through clathrin pathway (CME, 
clathrin-mediated endocytosis). In this condition, ubiquitination of the receptor is not required for its internalization. B) At higher doses 
of EGF, CME is equally active but a significant part of EGFR internalization proceeds also to an alternative pathway (NCE, non-clathrin 
endocytosis). The exact nature, and the molecular determinants, of this "alternative" pathway are still controversial. Essentially NCE is 
defined by its insensitivity to functional ablation (KD) of clathrin and sensitivity to cholesterol-interfering drugs, like filipin. Hence, its def-
inition as a "raft-dependent pathway". Internalization of EGFR through NCE requires receptor ubiquitination. Multiple roles of Eps15/R 
and epsin in the different internalization pathways are also shown (see main text for detailed explanations).
viously undiscovered requirement for these adaptors in
targeting Ub-conjugated cargo to clathrin-independent
endocytosis [42,50]. Indeed, both eps15/R and epsin
present single or multiple Ub interacting motifs (UIMs),
through which they recognize the ubiquitinated receptor
and mediate its clathrin-independent internalization
[42,51,52]. Hence, it is becoming clear that these endo-
cytic adaptors may play multiple roles in different endo-
cytic pathways, depending on which signal the cargo
protein presents and which endocytic route cargo uses.
Interestingly, these proteins are themselves modified by
monoUb in ligand-dependent manner [52,53]. By creat-
ing additional surfaces of interaction, monoubiquitina-
tion of adaptors could contribute to signal amplification
[1,4,53], as exemplified by findings that growth hormone
receptor internalization is crucially dependent on func-
tional Ub machinery, but does not require receptor ubiq-
uitination [54]. In this and other cases [55,56],
monoubiquitinated adaptors might be responsible for
sorting of receptors along the endocytic pathway. An alter-Page 4 of 12
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leagues [57]. In this model monoubiquitination of the
adaptor leads to an intramolecular interaction mediated
by the UBD that folds back on the Ub appended in cis.
This switch-off mechanism allows the detachment of the
adaptor from the ubiquitinated cargos [4,57]. At least for
eps15, evidence is accumulating in our laboratory that
argues against an intramolecular inhibitory interaction
mediated by the UIM (TW and SP, unpublished). It
should be mentioned that the precise role of monoubiq-
uitination could be distinct in the different adaptors and
that the present knowledge does not allow generalization
of one specific concept.
In conclusion, the emerging picture indicates that Ub can
regulate EGFR endocytosis and signalling in several ways.
On one hand, by targeting the receptor, Ub mediates its
internalization and degradation, leading to signal termi-
nation. On the other hand, by targeting the endocytic
machinery, Ub might contribute to the "endocytic" regu-
lation of signalling in time and space. The combination of
these Ub-based regulatory mechanisms together with oth-
ers, such as phosphorylation, contribute to generate the
wide variety of biological responses downstream of the
EGFR.
UBD specificity: recognition of signalling 
diversity
The identification of the first Ub binding modules has set
the stage for the discovery of a Ub-based network of pro-
tein:protein interactions [1]. Proteins carrying UBDs rep-
resent the downstream effectors able to recognize and
further transmit the Ub signal. In terms of structure and
affinity characteristic UBDs have been amply and excel-
lently reviewed [53,58,59]. Here, we concentrate on pos-
sible mechanisms of linkage-specific recognition.
Despite the increased number of high-resolution struc-
tural studies, no single domain can be accurately referred
to as mono- or polyubiquitin-specific binding domain. In
a systematic effort to define the factors responsible for
linkage-specific recognition, Pickart and co-workers exam-
ined the Ub interaction properties of 30 distinct UBA
(ubiquitin associated) domains and sorted them in four
different classes [60]. Class 1 domains, which include the
UBA domains from Rad23 and hHR23A, selectively recog-
nize lys48-linked chains. This preference is consistent
with the role of Rad23 as a modulator of proteasome
activity, although the UBA might be not essential for this
function. Class 2 domains preferentially bind lys63-
linked chains. Among others, this group includes the UBA
from Ede1, the yeast homolog of eps15, which mediates
protein trafficking typically associated with monoUb or
lys63-linked chains. Class 3 domains comprise many
UBAs that do not bind to Ub at all. Although it cannot be
excluded that they recognize Ub chains different from the
ones used or other Ub-like protein modifiers, these results
underline the need for experimental validation of bioin-
formatically identified UBD. The last class of UBA
domains bind to polyUb chains without any linkage spe-
cificity. Unfortunately, while the classification was cer-
tainly useful, it did not support any distinction based on
primary sequence comparison, leaving the molecular
basis for linkage-specific discrimination still unclear. It
should be noticed that the preference observed for an iso-
lated UBD could be different from the one observed for
the full-length protein. In vivo subcellular localization as
well as structural constraints might strongly influence the
type of Ub that Ub receptors are programmed to bind.
In some cases, preferences for lys48-linked chains can be
explained by the ability of a single UBD to interact with
two Ub moieties in 1:2 stoichiometry. NMR studies have
revealed the modes of interaction of the UBA domains of
hHRD23A and of Mud1 with two Ub molecules linked via
lys48 [22,61]. In both cases, the UBA appears to insert
into the di-ubiquitin making contact with both Ub moie-
ties. Interestingly, the hHRD23A UBA2 domain seems to
bind the lys48-linkage directly [22]. The recent character-
ization of the structure of the UIM (Ub-interacting motif)
of Hrs in complex with Ub revealed a comparable mode
of interaction [62]. Hrs is a key protein involved in the
sorting of ubiquitinated cargos. The authors showed that
UIM of Hrs is capable of binding two Ub molecules at the
same time through two interaction surfaces embedded on
the opposite sides of the same helix. Based on sequence
comparison, they identified a new subclass of UIMs that
was named DUIM (double-sided UIM). In addition to
increased avidity, a possible intriguing feature of these
domains is the potential for binding to topologically dis-
tinct chains, although this has not been experimentally
tested.
The protein NEMO, an essential regulator of NF-kB activa-
tion, represents an interesting case of chain-specific recog-
nition [63,64]. Pull-down experiments have
demonstrated that the region encompassing the second
coiled-coil and the leucine zipper motifs is able to bind
lys63-linked chains, but not chains linked through lys48
[63,64]. One physiological substrate of NEMO is the
receptor-interacting protein, RIP, which is indeed lys63-
ubiquitinated [65]. It has been proposed that NEMO pro-
tects RIP from the proteasomal degradation by preventing
the conversion of lys63-linked to lys48-linked polyubiq-
uitination promoted by the A20 protein [63,65].
Despite the high degree of conservation of the entire Ub
molecule throughout evolution, the majority of Ub recep-
tors contact the hydrophobic face of Ub, centred on Ile44.
A pioneering study performed in S. cerevisiae has identi-Page 5 of 12
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[66]. Recently three novel UBDs were reported to recog-
nize alternative surfaces of Ub. Using a two-hybrid screen-
ing approach with a mutated version of Ub (Ile44Ala)
Dikic and collegues identified the UBM (Ub binding
motif) present in Y-family translesion synthesis (TLS)
polymerases [67]. NMR studies showed that the UBM rec-
ognizes a Ub surface around Leu8, that is near, but not
overlapping with, Ile44. The presence of this domain
allows TLS polymerases to interact with ubiquitinated
PCNA after DNA damage [67,68].
The second non-canonical Ub binder is the ZnF_A20
domain present in Rabex-5, a Rab5 guanine nucleotide
exchange factor. Crystal structures have revealed that the
ZnF_A20 makes contacts with a polar patch centred on
Asp58, which is completely displaced from Ile44 [69,70].
Functionally, we have demonstrated that the ZnF_A20
domain is required, together with the adjacent MIU
(motif interacting with Ub) for the binding of Rabex-5 to
the activated and ubiquitinated EGFR [69]. The discovery
that a single Ub moiety can simultaneously engage two
different partners increases the complexity of Ub-based
network and provides interesting outlooks. For instance, it
can explain how Ub receptors promote trafficking of ubiq-
uitinated cargos along the endocytic route. The "hand-off"
mechanism previously proposed [53] is difficult to
hypothesize if the sole interaction surface on Ub is around
Ile44. If, instead, we envision a scenario in which Ub
receptors that recognize non-canonical surfaces of Ub are
intercalated with Ile44-specific Ub receptors, the hand-off
mechanism of trafficking of monoubiquitinated cargos
becomes plausible (Figure 3).
The third example of an alternative Ub recognition site is
represented by the UBD present in the deubiquitinating
enzyme isopeptidase T (IsoT or USP5), named ZnF_UBP.
This domain contains a unique, deep tunnel-like binding
pocket which can accomodate the C-terminus diglycine
motif of Ub [71]. In addition to this extensive interaction,
ZnF_UBP also binds to Ub around Ile36, while no con-
tacts with the Ile44 patch are evident. Functionally, IsoT is
responsible for the hydrolysis of unanchored polyUb
chains. It releases one Ub at a time, starting from the prox-
imal end of the chain [71]. Mutations in the ZnF_UBP
domain demonstrate that it is required for optimal cata-
lytic activation of IsoT. Given the different conformations
of adopted different types of polyUb chains, it is unclear
how IsoT can act on all of them. A speculative hypothesis
implicates the high flexibility of the C terminus of Ub that
can easily rotate in order to position the scissile bond of
alternatively linked polyubiquitin chains near the cata-
lytic site. The proximal Ub in the chain is immobilized via
the insertion of its C-terminus diglycine motif in the deep
invagination of the ZnF_UBP. Since ZnF_UBP does not
contact any lysine residues that could possibly be
involved in chain linkage, the chain could project out
from the proximal Ub in any direction, thus enabling IsoT
to trim any type of Ub chain.
E3 ligases: signalling-regulated enzymes
Ubiquitination is often induced by extracellular stimuli
and substrates are not constitutively recognized. Thus, the
activity of the ubiquitin system needs to be rapidly and
tightly modulated in order to gain specificity. This could
be achieved promoting or inhibiting substrate recognition
and/or modifying the catalytic activity of the conjugating
enzymes [72].
Regulation can occur via the subcellular localization of
the enzymes or of the substrates or via the binding to
"auxiliary" proteins. In the case of TGF-β signalling,
Smad7 acts as an adaptor protein and recruits the Smurf
E3 ligases to the TGF-β receptor [73]. In addition, Smad7
is able to stimulate the catalytic activity of Smurf2 by
recruiting and positioning the E2, UbcH7, in close prox-
imity to the HECT domain of Smurf2 [74]. Accessory pro-
teins may also have an inhibitory function, such as the
tumor suppressor protein ARF which blocks the E3 ligase
activity of Mdm2 leading to p53 stabilization [75].
Regulation can also occur through post-translational
modification of the substrate or of a component of the
ubiquitin conjugating machinery. Usually, the E3 ligase is
the key component of the machinery subject to regula-
tion, although post-translational regulation of E2
enzymes has recently been described [76-79].
Regulation by phosphorylation
In recent years, it has become clear that Ub regulation is
often dependent upon protein phosphorylation [72].
Phosphorylation may play a role in either the recognition
of substrate by the E3 ligase or the modulation of E3 enzy-
matic activity.
Substrate phosphorylation is a common and well-charac-
terized way of creating a binding site for the E3 ligase.
Many multisubunit RING E3s, such as Skp1-Cul1-F-box
protein (SCF) complexes, target their substrates for pro-
teasomal degradation in a phosphorylation-dependent
manner. Phosphorylated substrates are recognized and
recruited to the SCF core complex through one of the large
family of F-box adaptors proteins [80]. Cbl, a monomeric
RING E3 ligase involved in the ubiquitination of the
EGFR, binds its substrate through the N-terminal PTP
(phosphotyrosine binding) domain only after the recep-
tor is phosphorylated [34]. Phosphorylation might also
prevent substrate recognition/interaction by the E3. C-Jun
tyrosine phosphorylation within its PPXY motif by c-Abl
inhibits binding to its E3 ligase Itch and, as a conse-Page 6 of 12
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dation of c-Jun [81].
On the other side, E3 phosphorylation is now accepted as
an E3 regulatory mechanism. Its molecular consequences
are only beginning to be explored. Phosphorylation of an
E3 can generally inhibit or activate the enzymatic activity
towards specific substrates (for detailed examples see
[72]). In the case of negative regulation, recognition of the
substrate is generally impaired. In addition, E3 activity is
often shifted to self-ubiquitination or to another substrate
[82-84]. Alterations of the subcellular localization have
been described, as well [84-86].
Recently, Karin and colleagues have elucidated the mech-
anism of activation for the JunB E3 ligase Itch, which is
critically important in T helper cell differentiation [87].
After T cell receptor engagement, Itch undergoes JNK1-
mediated phosphorylation that greatly enhances its enzy-
matic activity. The authors found that under non-stimu-
lated conditions, Itch is inactive due to an intramolecular
interaction between its WW and HECT domains. After T-
cell stimulation, Itch is phosphorylated on three key resi-
dues (S199, T222, S232) within the proline-rich region.
This phosphorylation event weakens the intramolecular
interaction, most likely through electrostatic repulsions,
leading to a conformational change in the WW domain.
This conformational change releases the self-inhibitory
interaction, thus dramatically increasing the E3-ligase
activity [87]. In addition to undergoing serine/threonine
phosphorylation, Itch is tyrosine phosphorylated by Fyn,
a member of the Src family kinases, after T-cell stimula-
tion [88]. Various observations suggest a negative regula-
tion of Itch by tyrosine phosphorylation [88]. The
mechanism by which this happens is unclear, but it has
been proposed that tyrosine phosphorylation might steri-
cally inhibit the interaction between Itch and JunB [88].
Thus, Itch-mediated JunB degradation seems to be tightly
regulated by counterbalancing serine/threonine and tyro-
sine phosphorylation. It will be interesting to see if similar
mechanisms of regulation exist for other types of E3
ligases for which phosphorylation events by various extra-
cellular stimuli have been described [72].
"Hand-off" mechanism model for ubiquitinated cargosFigure 3
"Hand-off" mechanism model for ubiquitinated cargos. Ub receptors (A and C), recognizing the hydrophobic patch 
centred on Ile44 (depicted in black), are intercalated with others (B), recognizing different region of Ub (depicted in white). 
Rabex-5, through ZnF_A20 domain, recognizes the polar patch centred on Asp58 and represents an example of Ub receptors 
B. Endosome is depicted as prototype of trafficking organelles.Page 7 of 12
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E3 ligases can be regulated by ubiquitination. The sim-
plest possibility is that E3 ligases are modified by a polyu-
biquitin chain linked through lys48 and targeted for
proteasomal degradation. RING finger-containing E3s
often catalyze their own polyubiquitination, in addition
to polyubiquitination of their substrates [89]. HECT-E3s
are also capable of self-ubiquitination [53]. Self-ubiquiti-
nation is a well accepted auto-regulatory mechanism
which controls E3 ligase levels by degradation [90-92]. An
additional level of regulation can be achieved through dif-
ferent E3 ligases acting on one other. This concept might
help rationalize why, in some cases, different E3 ligases
are found in the same complex, such as, for instance, Cbl
and Nedd4 or AIP4 [93,94].
Two recent papers have shown a non-destructive regula-
tory function for Ub modifications of E3 ligases. In both
cases, the Ub modification enables the E3 ligases to pro-
mote monoubiquitination of their substrates [30,95]. Our
group has demonstrated that the ubiquitination of the
HECT-type E3 ligase Nedd4 is required for recognition of
a specific substrate, eps15 and confers to the enzyme the
ability to execute coupled monoubiquitination [95].
Eps15 is one of the Ub receptors, already described,
involved in EGFR internalization. Like many other Ub
receptors, eps15 becomes monoubiquitinated upon EGF
stimulation by a process known as coupled monoubiqui-
tination, which requires the presence of an intact UBD
[52,53]. Nedd4 is the bona fide E3 ligase for eps15 but no
stable interaction between these two proteins has been
detected [52]. Since the UIM:Ub interaction is required for
eps15 ubiquitination, we hypothesised that the UIM of
eps15 may bind a ubiquitinated form of Nedd4. Two pos-
sibilities were envisioned. In the first one that we called
"E3-thiolester model", the UIM would bind to the Ub
linked through the thiolesther bond at the Nedd4 catalytic
cysteine. The same Ub would be then directly transferred
to the substrate. In the second model, called "E3-isopep-
tide model", the UIM would bind to a covalently ubiqui-
tinated Nedd4 and then the catalytic cysteine would
transfer another Ub to the substrate. To distinguish
between the two models, a key experiment based on the
capacity of Nedd4 to undergo self-ubiquitination in vitro
was performed. The "E3-isopeptide model" predicts that
increasing the amount of Ub-conjugated Nedd4 in the
reaction should then increase monoubiquitination of
eps15. Conversely, if the "E3-thiol-ester model" is correct,
then eps15 ubiquitination should be indifferent to the
status of Nedd4. In agreement with the isopeptide model,
we found that ubiquitinated Nedd4 dramatically
enhanced the amount of eps15 monoubiquitination with
significantly faster kinetics. No differences were observed
when a conventional substrate for Nedd4 was used [95].
Thus, ubiquitination of the enzyme enables the E3 to rec-
ognize and ubiquitinate an additional substrate without
changing its catalytic activity. If this model might be appli-
cable to other UBDs capable of coupled monoubiquitina-
tion deserves further investigations.
In a completely different system, Ciechanover and col-
legues have demonstrated that self-ubiquitination of
Ring1B is required for subsequent monoubiquitination of
its substrate, H2A [30]. When the ability of Ring1B to
undergo self-ubiquitination was analysed, the authors
found that the chains generated by the enzyme are atypi-
cal, mixed polyUb chains that do not serve as a proteas-
ome targeting signal. With the help of an array of lys-
modified Ub molecules, the authors convincingly proved
that three lysines, namely lys6, lys27 and lys48, should be
present on the same ubiquitin molecule to achieve full
self-ubiquitination of Ring1B. What is the role of these
atypical chains? Surprisingly, when they tested H2A
monoubiquitination using Ub mutants they found that
the same lysine residues were necessary. To demonstrate
that self-polyubiquitination of Ring1B is required for H2A
monoubiquitination, the authors used an approach very
similar to the one used by Woelk et al. Ring1B was first
subjected to a self-ubiquitination reaction with wt or
lysine-less Ub and then purified and used to perform H2A
monoubiquitination. In agreement with the idea that self-
ubiquitination of Ring1B should occur prior or simulta-
neously with ubiquitination of the substrate, the lysine-
less Ub-modified Ring1B showed a significant reduction
in its activity toward H2A [30].
Unfortunately, the currently available tools do not allow
the detailed structure of the atypical chains generated by
Ring1B to be defined. Likely, they represent mixed
branched chains in which any Ub within the chain can be
conjugated with several others via different internal
lysines. The molecular function of the atypical mixed
chains attached to Ring1B is not clear yet, but it is tempt-
ing to speculate that the Ub chains might alter the struc-
ture of the E3, rendering it more active, or, as in the case
of Nedd4, changing its binding specificity. Whatever the
case, whether and how ubiquitination of E3 ligases is reg-
ulated in vivo remains to be established.
The fact that two totally unrelated E3 ligases, one of the
HECT-type and the other of the RING-type, both appear
to be regulated by ubiquitination, might indicate a more
general mechanism of regulation and suggest another
unexpected similarity between phosphorylation and
ubiquitination pathways. In the same way that kinases are
often activated by tyrosine phosphorylation in the signal-
ling cascade, E3 ligases appear to be activated by ubiquiti-
nation (Figure 4).Page 8 of 12
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Regulation of E3 activities by post-translational modificationsFig re 4
Regulation of E3 activities by post-translational modifications. A) Extracellular stimuli can induce various post-transla-
tional modifications of E3 ligases. This might result on a positive or a negative regulation of the ligase activity. Examples are 
reported (see main text for detailed explanations). The arrows represent the integration of numerous signals. pY, tyrosine 
phosphorylation; pS/T, serine or threonine phosphorylation; Ub, ubiquitination; Ub-like, neddylation or sumoylation. B) Com-
parison between the phospho-based network and the Ub-based network. Similarity includes recognition by dedicated protein 
domains (SH2 and UIM are example), inducibility by upstream signals and reversibility (DUBs work as phosphatases). In addi-
tion, kinases are often activated by tyrosine phosphorylation in the signalling cascade while E3 ligases could be activated by 
ubiquitination.
Cell Division 2007, 2:11 http://www.celldiv.com/content/2/1/11Finally, Ub E3 ligases can be modified by ubiquitin-like
modifiers, as well (Figure 4). Neddylation of cullin scaf-
fold family members strongly activate the E3 activity of
cullin-based ubiquitin E3s, such as SCFs [96,97]. Mdm2
increases its activity towards p53 upon sumoylation,
while desumoylation increases Mdm2 self-ubiquitination
and degradation, thereby stabilizing p53 [98].
Conclusions and perspectives
Ubiquitin modification irreversibly or reversibly changes
the fate of a target protein. Ubiquitination is regulated at
different levels by the enzymes that catalyse the reaction,
the properties of the substrate, the presence of UBDs or
the activity of the enzymes that reverse the reaction, the
DUBs. All these hardware components are frequently and
rapidly modulated by extracellular signals (for example,
growth factors, pro-inflammatory cytokines and UV dam-
age) in a signalling cascade of ubiquitination events that
mirrors the well-characterized phosphorylation cascade.
Moreover, the two pathways are strongly interlinked. We
have described how the phosphorylation of substrates or
E3 ligases is, in some cases, a prerequisite for subsequent
ubiquitination. We can hypothesize that the opposite
might also occur as the presence of a UIM and of a RING
domain in the MEKK1 enzyme seems to suggest. This
additional layer of complexity is further amplified by a
number of ubiquitin-like modifications present in the
cell, not even discussed in the present review. We are only
just starting to understand the basis of the system. It is pre-
dictable that the coming, exciting years will provide con-
siderable insight into the regulation of diverse pathways,
including cell proliferation and apoptosis, for which ubiq-
uitination is of paramount importance. Uncovering the
basic mechanisms in the ubiquitination system will help
us to understand how their subversion contributes to dis-
eases, such as cancer, and will provide a new window of
opportunity for the development of novel therapeutic
strategies of intervention.
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